3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
4
Withdrawn
1
Completed
1
Available
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
7
Other hematologic neoplasm
5
Plasma cell
1
Myeloid
1
Lymphoid
1
Conditions
Lymphoma
1600
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1283
Lymphoma, Non-Hodgkin
1231
Leukemia, Lymphocytic, Chronic, B-Cell
1090
Lymphoma, Follicular
979
Lymphoma, Large B-Cell, Diffuse
854
Leukemia
790
Hodgkin Disease
777
Lymphoma, Mantle-Cell
676
Leukemia, Myeloid, Acute
540
Burkitt Lymphoma
507
Lymphoma, B-Cell, Marginal Zone
490
Multiple Myeloma
483
Myelodysplastic Syndromes
371
Lymphoma, Large-Cell, Immunoblastic
366
Recurrence
365
Lymphoma, T-Cell, Cutaneous
313
Neoplasms
309
Waldenstrom Macroglobulinemia
307
Lymphoma, Large-Cell, Anaplastic
255
Mycosis Fungoides
252
Lymphoma, B-Cell
231
Sezary Syndrome
229
Blast Crisis
210
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
208
Myeloproliferative Disorders
205
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
189
Neoplasms, Plasma Cell
188
Leukemia, Myeloid, Accelerated Phase
186
Leukemia, Myeloid, Chronic-Phase
179
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thalassemia
×
Lymphoid
×
Clear all
NCT01758042
2026-03-06
BMT
Massachusetts General Hospital
Phase NA
Completed
10 enrolled